HNSCC

Testing a new treatment approach for HNSCC – ECOG-ACRIN Cancer Research Group

ECOG-ACRIN Cancer Research Group shared a post on X:

“April is Head and Neck Cancer Awareness Month!

Clinical Trial EA3191 is testing a new treatment approach for patients with squamous cell carcinoma of the head and neck (HNSCC) that has come back after initial therapy.

Learn more.”

More posts featuring ECOG-ACRIN Cancer Research Group.

cancer ECOG-ACRIN Cancer Research Group Head and Neck Cancer Awareness Month HNSCC OncoDaily Oncology